151 related articles for article (PubMed ID: 11859)
21. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
[TBL] [Abstract][Full Text] [Related]
22. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.
Storb R; Thomas ED; Buckner CD; Clift RA; Deeg HJ; Fefer A; Goodell BW; Sale GE; Sanders JE; Singer J; Stewart P; Weiden PL
Ann Intern Med; 1980 Jan; 92(1):30-6. PubMed ID: 6985782
[TBL] [Abstract][Full Text] [Related]
23. Marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Kawahara K; Witherspoon RP; Storb R
Am J Hematol; 1992 Apr; 39(4):283-8. PubMed ID: 1553957
[TBL] [Abstract][Full Text] [Related]
24. [Bone marrow transplantation in leukemia and aplastic anemia].
Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation in 65 patients with severe aplastic anemia.
Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
[TBL] [Abstract][Full Text] [Related]
26. Retransplantation of human bone marrow. Two immunosuppressive drug regimens.
Kersey J; Roloff J; Hokeness S; Johnson FL; Nesbit M; Krivit W
Transplantation; 1975 Jun; 19(6):475-8. PubMed ID: 237352
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow transplantation for Fanconi anemia. Adjustment of the dose of cyclophosphamide for preconditioning.
Yabe M; Yabe H; Matsuda M; Hinohara T; Oh Y; Hattori K; Ishikawa K; Ohshima T; Yamamoto H; Kato S
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):377-82. PubMed ID: 8214359
[TBL] [Abstract][Full Text] [Related]
28. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
Tsoi MS; Storb R; Weiden PL; Thomas ED
J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
[TBL] [Abstract][Full Text] [Related]
30. Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.
Mathé G; Schwarzenberg L
Transplant Proc; 1976 Dec; 8(4):595-602. PubMed ID: 136773
[TBL] [Abstract][Full Text] [Related]
31. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.
Champlin RE; Horowitz MM; van Bekkum DW; Camitta BM; Elfenbein GE; Gale RP; Gluckman E; Good RA; Rimm AA; Rozman C
Blood; 1989 Feb; 73(2):606-13. PubMed ID: 2644980
[TBL] [Abstract][Full Text] [Related]
32. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.
Witherspoon RP; Storb R; Ochs HD; Fluornoy N; Kopecky KJ; Sullivan KM; Deeg JH; Sosa R; Noel DR; Atkinson K; Thomas ED
Blood; 1981 Aug; 58(2):360-8. PubMed ID: 6454452
[TBL] [Abstract][Full Text] [Related]
33. Selection of patients for bone marrow transplantation in severe aplastic anemia.
Camitta BM; Rappeport JM; Parkman R; Nathan DG
Blood; 1975 Mar; 45(3):355-63. PubMed ID: 1090310
[TBL] [Abstract][Full Text] [Related]
34. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.
Doney KC; Weiden PL; Storb R; Thomas ED
Am J Hematol; 1981; 11(1):1-8. PubMed ID: 7023233
[TBL] [Abstract][Full Text] [Related]
35. Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia.
Ramsay NK; Kim TH; McGlave P; Goldman A; Nesbit ME; Krivit W; Woods WG; Kersey JH
Blood; 1983 Sep; 62(3):622-6. PubMed ID: 6349713
[TBL] [Abstract][Full Text] [Related]
36. Relevance of colony forming assays to bone marrow transplanation with particular reference to grafting for aplastic anaemia.
Gordon MY
Br J Haematol; 1979 May; 42(1):61-71. PubMed ID: 37884
[TBL] [Abstract][Full Text] [Related]
37. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.
Niederwieser D; Pepe M; Storb R; Loughran TP; Longton G
Br J Haematol; 1988 May; 69(1):23-8. PubMed ID: 3289603
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplantation for aplastic anemia.
Storb R
Cell Transplant; 1993; 2(5):365-79. PubMed ID: 8162278
[TBL] [Abstract][Full Text] [Related]
39. Recovery from aplastic anemia following attempted marrow transplantation.
Thomas ED; Storb R; Giblett ER; Longpre B; Weiden PL; Fefer A; Witherspoon R; Clift RA; Buckner CD
Exp Hematol; 1976 Mar; 4(2):97-102. PubMed ID: 770181
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
